Holen Sie sich die Stockscreener-App
49.00
1.03%
-0.51
Supernus Pharmaceuticals Inc Aktie (SUPN) Neueste Nachrichten
Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Supernus Pharmaceuticals Inc. (SUPN) Stock Price | Live Quotes & Charts | NSD - StocksToTrade
Supernus Pharmaceuticals Shares Rise After Piper Sandler Upgrade - MarketScreener
Supernus Pharmaceuticals: A Rising Pharma Contender? - StocksToTrade
Supernus Pharmaceuticals (SUPN) Stock Is Up, What You Need To Know - TradingView
SUPN: Piper Sandler Raises Price Target to $65 and Upgrades Rati - GuruFocus
Piper Sandler Upgrades Supernus Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $65 From $40 - MarketScreener
Can Supernus Pharmaceuticals Inc. stock attract ESG capital inflowsJuly 2025 Big Picture & Weekly Market Pulse Updates - newser.com
How Supernus Pharmaceuticals Inc. stock performs during Fed tightening cycles2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com
Published on: 2025-10-09 05:01:01 - newser.com
Supernus (SUPN) Receives Upgraded Rating Amid Promising Product Outlook - GuruFocus
How to use Fibonacci retracement on Supernus Pharmaceuticals Inc.2025 Price Action Summary & Safe Entry Zone Tips - newser.com
Is now a turning point for Supernus Pharmaceuticals Inc.July 2025 Earnings & Real-Time Sentiment Analysis - newser.com
Supernus Pharmaceuticals Hits New 52-Week High of $49.66 - Markets Mojo
Will Supernus Pharmaceuticals Inc. rebound enough to break evenDollar Strength & Weekly Top Performers Watchlists - newser.com
How geopolitical tensions affect Supernus Pharmaceuticals Inc. stockCPI Data & Comprehensive Market Scan Insights - newser.com
Why Supernus Pharmaceuticals Inc. stock could be next big winnerJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Using R and stats models for Supernus Pharmaceuticals Inc. forecasting2025 Macro Impact & Reliable Volume Spike Trade Alerts - newser.com
Is Supernus Pharmaceuticals Inc. stock poised for growthPortfolio Growth Summary & Real-Time Market Trend Scan - newser.com
Is Supernus Pharmaceuticals Inc. stock cheap compared to fundamentalsAnalyst Upgrade & Daily Stock Trend Reports - newser.com
Wall Street Zen Downgrades Supernus Pharmaceuticals (NASDAQ:SUPN) to Hold - Defense World
Smart tools for monitoring Supernus Pharmaceuticals Inc.’s price actionQuarterly Portfolio Review & High Conviction Buy Zone Alerts - newser.com
Real time social sentiment graph for Supernus Pharmaceuticals Inc.Trade Volume Summary & Real-Time Buy Zone Alerts - newser.com
Supernus Pharmaceuticals, Inc. $SUPN Shares Purchased by GAMMA Investing LLC - Defense World
What MACD signals say about Supernus Pharmaceuticals Inc.Market Volume Summary & Low Drawdown Momentum Trade Ideas - newser.com
Supernus Pharmaceuticals stock hits 52-week high at 48.47 USD - Investing.com India
Supernus Pharmaceuticals stock hits 52-week high at 48.47 USD By Investing.com - Investing.com Australia
Supernus Pharmaceuticals (SUPN): Is the Current Share Price a Fair Reflection of Its True Valuation? - Yahoo Finance
Supernus Pharmaceuticals (NASDAQ:SUPN) shareholders have earned a 18% CAGR over the last five years - simplywall.st
Supernus Pharmaceuticals (NASDAQ:SUPN) Given New $63.00 Price Target at Cantor Fitzgerald - Defense World
Supernus Pharmaceuticals Hits New 52-Week High of $48.00 - Markets Mojo
SUPN: Cantor Fitzgerald Increases Price Target to $63, Maintains Overweight Rating | SUPN Stock News - GuruFocus
1.54%
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):